Zanubrutinib Combined With Standard Chemotherapy in the Treatment for Patients With Diffuse Large B Cell Lymphoma
Clinical trial NCT04668365 · SUSPENDED
Trial details
- NCT number
- NCT04668365
- Sponsor
- Henan Cancer Hospital
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-25
- Primary completion
- 2024-11-20
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.